Clinical Trials
Save
MADIT Trial
Summary: Evaluated patients with an ischemic cardiomyopathy and EF < 35% and inducible, but non-suppressible ventricular tachycardia on EP study with implantable cardioverter defibrillators (ICDs) versus none. The group with ICDs had a significant mortality reduction.
Original Publication:
N Engl J Med. Dec 1996;26;335(26):1933-40.
Eponym: Multicenter Automatic Defibrillator Implantation Trial